Semaglutide
A GLP-1 receptor agonist. It helps regulate appetite and fullness and improves blood-sugar control, given as a once-weekly injection.
GLP-1 medications such as semaglutide and tirzepatide can be powerful tools for weight management, but only when prescribed after a proper medical assessment and paired with nutrition and follow-up. At Nuwendo, endocrinology and nutrition doctors decide if they are right for you, and our nutritionist-dietitians make sure the results last.
They are prescription medicines that act on the body's appetite and blood-sugar signals. They are not a diet, and they are not for everyone.
A GLP-1 receptor agonist. It helps regulate appetite and fullness and improves blood-sugar control, given as a once-weekly injection.
A dual GIP and GLP-1 receptor agonist. It acts on two hormone pathways involved in appetite and metabolism, also given once a week.
Both require a physician's assessment and prescription. Your doctor reviews your history, labs and risks before recommending either one.

GLP-1 therapy sits inside the full Nuwendo journey, so it is supported by data, nutrition and close follow-up.
Medications are tools, not shortcuts. They work best when combined with proper nutrition and follow-up, and they are not suitable for everyone. Your Nuwendo doctor will tell you honestly whether they fit your situation.
Only a doctor can answer that after assessing you. These are the situations our doctors most often evaluate.
Adults whose weight is affecting their health, especially when other approaches have not been enough.
People with prediabetes, type 2 diabetes or metabolic syndrome, where blood-sugar control is a priority.
Hypertension, PCOS, fatty liver or other conditions where weight loss is part of the treatment plan.
Still curious? Email us at info.nuwendoph@gmail.com.
Yes, when it is medically appropriate. Prescription depends on your medical history, risk profile, and physician assessment. If indicated, your plan includes education on use, monitoring, side effect checks, and scheduled follow-ups.
Semaglutide is a GLP-1 receptor agonist. Tirzepatide acts on two pathways, GIP and GLP-1. Both are once-weekly prescription injections; your doctor chooses based on your goals, history and how you respond.
The most common are gastrointestinal, such as nausea, fullness, constipation or diarrhea, especially when starting or increasing the dose. This is why Nuwendo schedules a two-week follow-up to check how you are doing and adjust early.
Weight can return if the habits behind it have not changed. Nuwendo pairs medication with a personalized nutrition plan and monthly follow-ups, then plans maintenance and tapering when appropriate to help prevent rebound weight gain.
Our Weight Management pathway (₱3,700) includes a consultation with an endocrinologist and nutrition doctor, a follow-up for lab interpretation or peptide initiation, and a nutrition plan session. Your doctor will advise if an in-person visit is needed. See the pathway.
Personalized nutrition plans and calorie guidance from registered nutritionist-dietitians.
Learn moreEndocrinology, nutrition and internal medicine doctors working with dietitians.
Learn moreEight guided steps from first consultation to lasting results.
See the journeyBook your metabolic assessment today. From your first consultation to long-term success, we guide you every step of the way.